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1. Introduction  
In anxiety research, relative few psychophysiological studies have been conducted. In this 
chapter, we presented previous studies that used different psychophsiological markers that 
can be further utilized in future research. However, there are a few things to be considered 
when psychophysiological markers are used in anxiety studies, first of which may be genetic 
factors. Genetic factors influence vulnerability to anxiety disorders. There are several genetic 
polymorphisms associated with anxiety disorders among which are the serotonin-transporter-
linked polymorphic region (5-HTTLPR), the Catechol-O-methyltransferase (COMT), and the 
brain-derive neurotrophic factor (BDNF) gene variants. We first presented studies that 
invsestigated the relationship between these genetics variants and anxiety disorders. Also, it 
has been suggested that anxiety disorders are characterized by abnormal neural activity—
amygdala hyperactivity and dysfunctional prefrontal activity—and cognitive bias favoring 
threat-relevant stimuli (Cisler et al., 2010; McClure et al., 2007; Nitschke et al., 2009; Whalen et 
al., 2008). We will present different psychophysiological markers that have been used to study 
dysfunctional neural, serotonergic, cognitive and autonomic activites associated with anxiety 
disorders. They include: (1) a loudness dependence of the auditory evoked potential (LDAEP) 
which is proposed to be associated with serotonin activity, (2) various components of the 
event-related potentials [P1, P2, N300, P3b, early posterior negativity (EPN), late positive 
potential (LPP), and error-related negativity (ERN)] that reflect altered neural activity in 
anxiety disorders and (3) the reduced heart rate variability (HRV) which indicates autonomic 
dysregulation associated with increased sympathetic and decreased vagal control of the heart. 
Particularly, in this chapter, we introduced the loudness of the auditory evoked potential 
(LDAEP) as a possible psychophysiological marker that can be utilized in anxiety research. 
Our previous studies revealed that patients with different subtypes of anxiety disorders 
produced distinctive LDAEPs and that the LDAEP could play an important role in predicting 
the efficacy of selective serotonin reuptake inhibitor (SSRI) treatment in anxiety disorders 
(Park et al., 2010, 2011). We suggest that utilizing the LDAEP along with other various ERP 
components indicating neural and cognitive dysfunctions associated with anxiety disorders 
may enhance our understanding of the etiology and maintenance of anxiety disorders. Also, it 
is important to understand how they interact with each other and with other environmental 
stressor to reinforce or to exacerbate anxiety symptoms (see Figure 1). Of clinical relevance is 
whether these psychophysiological markers may play a role in predicting clinical outcome of 
different treatment.  
www.intechopen.com
 
Anxiety Disorders 
 
204 
 
Fig. 1. Development of anxiety disorders and research methods that can be used in each stage. 
2. Genetic predispositions of anxiety symptoms 
Anxiety disorders have genetic predispositions and it is critical to consider individuals’ 
genetic predispositions to develop anxiety prone characteristics and anxiety disorders. 
Several anxiety-related genetic markers have been identified, one of which includes the 
serotonin transport promoter polymorphism (5-HTTLPR). The dysfunctional serotonergic 
system (5-hydroxytryptamine or 5-HT) is known to be implicated in anxiety and fear 
(Harmer et al., 2004). In human, serotonergic raphe neurons project to different brain 
structures (e.g., cortex, amygdala, hippocampus) and are associated with integrating various 
functions including emotion, cognition, motor function, pain, circadian and neuroendocrine 
functions such as food intake, sleep and sexual activity (Lesch et al., 1997). The 5-HT 
transporter (5-HTT) plays a vital role in regulating serotonergic neurotransmission by 
facilitating the reuptake of 5-HT from the synaptic cleft (Lesch et al., 1996; Hariri et al., 
2002). Lesch and colleagues (1996, 1997) identified a relatively common polymorphism in 
the promoter region of the serotonin transporter gene, which results in two different 
alleles—the short (s) and long (l). Research has showed that the 5-HTTLPR plays a functional 
role in regulating 5-HTT expression and 5-HTTLPR genotype may modulate 5-HTT 
expression (Lesch et al., 1996; Lesch et al., 1997). Individuals carrying one or two copies of 
the s form of 5-HTTLPR were associate with almost 50% reduction in 5-HTT availability 
compared to individuals homozygous for the l variant (Lesch et al., 1996; Lesch et al., 1997; 
Hariri et al., 2002). As a result, it has been reported that s-carriers were associate with 
increased anxiety-related behaviors and greater risk for developing anxiety in stressful life 
situations compared to individuals homozygous for the l variant (Lesch et al., 1996; Lesch et 
al., 1997; Hariri et al., 2002). Research also indicated that allelic differences in the 5-HTT may 
modulate activity of neural circuits (Heinz et al., 2005; Pezawas et al., 2005). Health 
individuals carrying one or two copies of the s allele showed greater activity in the 
amygdala in response to fearful stimuli (Heinz et al., 2005). Also, individuals with the s 
allele showed altered coupling of prefrontal-amygdala feedback circuit—which may lead to 
dysfunctional amygdala regulation in response to fearful stimuli—compared to individuals 
homozygous of the l allele (Heinz et al., 2005; Pezawas et al., 2005).  
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Another gene associated with anxiety disorders is the Catechol-O-methyltransferase (COMT) 
genetic variation (Funke et al., 2005). COMT is an enzyme that plays an important role in the 
metabolism of brain dopamine and norepinephrine (Gadow et al., 2009). The COMT gene can 
be found in chromosome 22q11 and contains several single nucleotide polymorphisms (SNPs) 
that are functionally important. For example, Val158Met (rs4680)—associated with encoding 
either valine (Val) or methionine (Met)—plays an important role in modulating COMT activity 
in the prefrontal cortex (Harrison et al., 2008). Current evidences suggest that Val158Met may 
be associated with anxiety disorders, particularly bipolar disorder, via controlling dopamine 
activity in the prefrontal cortex (Funke et al.,2005). Individuals with Val158 homozygous 
showed 35-50% higher COMT activity in human dorsolateral prefrontal cortex than those with 
Mel158 homozygous (Harrison et al., 2008). Although Met-COMT is considered to play an 
important role in the development of bipolar disorder, there exists evidence that Val-COMT is 
also associated with bipolar disorder (Funke et al., 2005).  
Lastly, the brain-derived neurotrophic factor (BDNF) gene variants are suggested to be 
linked with anxiety disorders (Chen et al., 2006; Gadow et al., 2009). BDNF is a neurotrophin 
that plays an important role in neuronal growth, differentiation, and synaptic plasticity 
(Chen et al., 2006; Gadow et al., 2009; Rasmusson et al., 2002). BDNF is also associated with 
learning and memory and modulates aggression (Rasmusson et al., 2002). It has been 
reported that BDNF plays a role in mediating effects of stress (Rasmusson et al., 2002). 
Reduced BDNF expression in the hippocampus was observed in response to stress, which 
may contribute to hippocampus-dependent memory deficits and the decreases in 
hippocampal volume associated with patients with post-traumatic stress disorder (PTSD; 
Rasmusson et al., 2002). Recent studies investigated the relationship between a SNP in the 
BDNF gene, Val66Met, and psychopathology, which yielded conflicting results (Jiang et al., 
2005). In an animal study, when exposed to stress, BDNF Met/Met mice demonstrated 
anxiety-related behaviors and were not responsive to the antidepressant, fluoxetine (Chen et 
al., 2006). Studies showed that Val66 allele were associated with greater neuroticisim scores, 
suggesting that individuals with the Val allele may have increased risk for developing 
anxiety or depression (Hünnerkopf et al., 2007; Sen et al., 2003). However, no association 
between BDNF Val66Met genotypes and neuroticisim was observed in Asian female 
participants (Tsai et al., 2004). BDNF Met66 allele was found to be a risk allele for anxiety 
and depression (Jiang et al., 2005) whereas other found it to be a protective allele for 
obsessive-compulsive disorder (OCD; Hall et al., 2003). In sum, BDNF may be related to 
anxiety disorder though it is yet to be determined which specific variant is responsible for 
the pathogenesis of anxiety disorders (Gadow et al., 2009).    
So far, we have presented different candidate genetic marker of anxiety disorders. To have 
better understanding of anxiety disorders, it would be important to identify genetic 
polymorphisms associated with anxiety disorders and study together with 
psychophysiological markers which will be discussed later.  
3. Neurophysiological and cognitive characteristics of anxiety disorders 
Anxiety disorders are characterized by altered neurophysiological and cognitive functions. 
Various psychophysiological markers used in anxiety research may reflect these altered 
neural and cognitive characteristics of anxiety disorders. Here, we briefly described altered 
neural activity and dysfunctional cognitive processing of threat-relevant information in 
people with anxiety disorders.  
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3.1 Amygdala hyperactivity and reduced PFC function  
Amygdala hyperactivity has been considered as an important neural characteristic of 
anxiety disorders (Bar-Haim et al., 2005; Dannlowski et al., 2007; McClure et al., 2007). 
Previous functional brain imaging studies indicated that anxiety disorders are linked with 
hyperactivity of the amygdala in response to anxiety provoking tasks (e.g., public speaking), 
fear-conditioning, and viewing face pictures with emotionally negative expressions (Phan et 
al., 2006). Also, functional magnetic resonance imaging (fMRI) studies revealed that effective 
treatment produced significantly reduced amygdala activity in patients with social phobia 
(Kilts et al., 2006; Furmark et al., 2002). Patients characterized with greater amygdala 
hyperactivity before treatment responded better to treatments such as SSRI medications and 
cognitive behavioral therapy (CBT; McClure et al., 2007). More recently, fMRI studies also 
revealed that high-trait anxiety individuals showed reduced activity in anterior cingulate 
cortex (ACC)—associated with conflict monitoring—and lateral prefrontal cortex (lateral 
PFC)—related with attentional control over threat-relevant distractors (Bishop et al., 2004). 
Patients with generalized anxiety disorder (GAD) patients who showed greater activation in 
ACC in response to or in anticipation of aversive pictures were associated with better 
treatment outcome (Nitschke et al., 2009; Whalen et al., 2008). In addition, GAD patients 
who showed greater activation in the ventrolateral prefrontal cortex—associated with 
emotional regulation by exerting inhibitory control over subcortical structures—had fewer 
anxiety symptoms (Monk et al., 2006). Therefore, anxiety disorders may be characterized by 
amygdala hyperactivity—associated with heighten sensitivity to motivation-relevant 
stimuli—and reduced PFC activity—resulting in the lack of top-down attentional control 
and emotional regulation (Bishop et al., 2004; McClure et al., 2007; Monk et al., 2006).  
3.2 Cognitive characteristics of anxiety disorders 
It has been well established that anxious individuals exhibit attentional biases toward 
threat-relevant stimuli (Cisler et al., 2010; Mathews et al., 1997). Anxiety-related attentional 
biases are typically observed in three different ways: (1) faster detection to threat-relevant 
stimuli relative to nonthreat stimuli, (2) difficulties in disengaging attention away from 
threat stimuli (sustained attention to threat stimuli), and (3) attentional avoidance of where 
threat-relevant stimuli are presented (Cisler et al., 2010; Fox et al., 2001; Koster et al., 2004; 
2005). Initially, anxiety-related attentional biases were studied in the emotional Stroop task. 
In the task, threat or neutral words were written in different colors and participants were 
instructed to name the color of ink while ignoring the meaning of the word (Cisler et al., 
2010). Research showed that high-trait anxiety participants were slower to name the color of 
ink in which threaten words were written, particularly to items relevant to their anxiety 
conditions. For instance, Vietnam combat veterans with Post-Traumatic Stress Disorder 
(PTSD) and without PTSD were asked to name the color of PTSD-related words,OCD-
related words, positive words, and neutral words (McNally et al., 1993). Veterans with 
PTSD took longer to name the color in which PTSD-related words were written relative to 
veterans without PTSD who showed no difference in reaction times across different types of 
the words. Similarly, slower responses were observed to read threat-relevant words in 
patients with GAD (Mathews & MacLeod, 1985) and panic disorder (McNally et al., 1994). 
Highly anxious non-clinical participants showed negativity bias even though they could not 
consciously aware of the presence of threat-relevant stimuli (MacLeod and Rutherford, 
1992). Moreover, performances on the masked emotional Stroop task predicted later 
emotional reactivity (Den Hout et al., 1995). 
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Fox and her colleagues (2001) adapted Posner’s spatial cuing task to systematically 
investigate different components of anxiety-related attention bias (Posner & Petersen, 1990). 
In the spatial cuing task, a target is preceded by a cue which can be either “central” (e.g., an 
arrow presented at the center of the display pointing one of two peripheral boxes in which 
the target would subsequently appear), or “peripheral” (e.g., an abrupt luminance of one of 
the peripheral boxes; Posner et al., 1990; Posner et al., 2007; Bartolomeo et al., 2001). When 
the cue appears on the same display that a target appears, it is considered to be a valid trial 
because the cue correctly predicts the location in which the target appears. However, when 
the cue fails to predict where the target will appear, it is considered to be invalid. In valid 
trials the detection of targets is facilitated (cuing benefits) whereas the detection of targets is 
delayed in invalid trials (cuing costs). In the modified emotion spatial cuing task, 
emotionally charged words or pictures were used as cues (Fox et al., 2001; Vuilleumier et al., 
2009). If high-trait anxiety participants automatically draw their attention to threat-relevant 
stimuli, their response to targets following valid threat-relevant cues should be fast (Fox et 
al., 2001). If high-trait anxiety participants have a difficulty in disengaging their attention 
from threat-relevant stimuli, then their responses to targets following invalid threat-related 
stimuli should be slow (Fox et al., 2001). In the first study, Fox et al. (2001) found that 
attentional disengagement from threat-relevant words took longer compared to neutral or 
positive words. However, there was no difference between high and low-trait anxiety 
participants. In the second study, they used schematic faces with ‘angry,’ ‘neutral,’ and 
‘happy’ facial expressions. When a cue duration period increased to 250 ms, only high 
anxious individuals showed the delayed attentional disengagement from angry faces. Fox 
and colleague (2001) suggested that regardless of anxiety level, people were initially drawn 
to threat-relevant information for a brief period of time (about 100 ms). However, low-trait 
anxiety participants were capable of quickly disengaging their attention from threat-
relevant, positive and neutral information whereas high-trait anxiety participants were less 
successful in disengaging their attention from the location in which threat-related 
information was presented.  
Recent studies suggested that high-trait anxiety is associated with the “vigilance-avoidance” 
attentional patterns in response to threat-relevant information, which may account for the 
maintenance of anxiety (Koster et al., 2006). The initial attention to mildly and highly 
threatening information may trigger the constant processing of fearful information and 
interfere with engaging in goal-directed behaviors (Koster et al., 2006). Faster detection of 
mildly and highly threatening information trigger anxious conditions in high-trait anxiety 
participants, which reinforces them to avoid threatening information in an attempt to reduce 
anxiety (Koster et al., 2006). However, this strategic attentional avoidance may not be a good 
coping strategy because it can lead to a failure of habituation to threaten stimuli and 
constantly remind of fear (Koster et al., 2006). Koster and colleagues (2005, 2006) used 
neutral, mildly and highly threatening pictures as cues and reported that when picture cues 
were presented at 100 ms, high-trait anxiety participants exhibited faster attentional 
engagement and slower attentional disengagement in response to highly threatening 
pictures compared to low-trait anxiety participants. However, when picture cues were 
presented longer, 500 ms, high-trait anxiety participants showed slower attentional 
engagement to highly and mildly threatening cues, which may suggest attentional 
avoidance to highly threatening stimuli (Koster et al., 2006).  
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Interestingly, there is evidence suggesting that the 5-HTTLPR s allele—genetic 
predispositions to anxiety—may be related with anxiety-related cognitive bias (Beck, 2008). 
Twenty-seven psychiatric inpatients who carried s allele of the promoter region of the 5-
HTTPR showed anxiety-related attentional biases favoring threat-relevant words compared 
to patients with homozygous for the l variant (Beevers et al., 2007). Fox and colleagues 
recently showed that healthy individuals with homozygous for the l allele were 
characterized by a marked avoidance of negative stimuli and a vigilance for positive stimuli 
whereas s-allele carriers did not show such protective attentional pattern (Fox et al., 2009). 
Therefore, allelic variation of the promoter region of the serotonin transporter gene may 
influence the way in which an individual processes emotional materials.  
4. The event-related potentials (ERP) components used to study anxiety 
disorders 
Several ERP components have been used to study serotonergic, neural, and cognitive 
dysfunctions associated with anxiety disorders. We provided underlying mechanisms of the 
loudness dependence of the auditory evoked potential (LDAEP) and presented studies that 
used the LDAEP in anxiety research. Also, researchers have studied other ERP components 
that reflect neural mechanisms of cognitive bias toward threat-relevant stimuli commonly 
observed in patients with anxiety disorders. 
4.1 Loudness of the auditory evoked potential  
It has been proposed that the LDAEP—which measures activity in the primary auditory 
cortex in response to different tone intensities—indicates the functioning of the central 
serotonergic system (Hegerl et al., 1993; Juckel et al., 1999). More specifically, the LDAEP is 
defined as the linear regression slope calculated from five amplitudes of N1/P2 components 
in response to increasing five auditory tones (Senkowski et al., 2003; see Figure 2). Research 
has indicated that the LDAEP is inversely related to central serotonergic activity: a stronger 
LDAEP indicates lower serotonergic neurotransmission and vice versa (Juckel et al., 1999, 
Park et al. 2010). 
Initial evidence that linked the LDAEP and the serotonergic system came from animal 
studies (O’Neill et al., 2008). Administrating quipazine maleate—a 5-HT2 receptor agonist—
reduced the amplitude of N1/P2 components whereas administrating spiperone—a 5-HT1A 
receptor antagonist—increased the N1/P2 amplitude in rats (Manjarrez et al., 2005). 
Administrating the precursor of 5-HT, L-tryptophan, was associated with the reduced 
amplitude of N1/P2 components (Manjarrez et al., 2005). Other studies showed that the 
LDAEP was inversely correlated with the concentration of 5-hydroxyindoleacetic acid (main 
metabolite of serotonin) in cerebrospinal fluid (von Knorring et al, 1981). High scores in the 
serotonin syndrome scale were associated with weaker LDAEPs and vice versa in 
depressive patients who underwent SSRI treatment (Hegerl et al., 1998). Individuals scored 
high on measures of sensation seeking and impulsiveness were associated with stronger 
LDAEP—potentially indicating reduced serotonergic function (Brocke et al., 2000; Hegeral 
et al., 1995). So far, there have been three studies that investigated the relationship between 
allelic variants of the seroton transporter gene and the LDAEP. It has been found that 
individuals homozygous for the l variant exhibited lower LDAEP (Gallinat et al., 2003) 
whereas others (Strobel et al., 2003; Hensch et al., 2006) reported that the l allele carriers 
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showed stronger LDAEP. These studies provide evidence that the LDAEP is linked with the 
serotonin transporter polymorphism although there are inconsistencies in predicting 
directional changes in serotonin neurotransmission (O’Neill et al., 2008). 
 
 
Fig. 2. Subject 1 possesses a steep LDAEP (a large increase in N1/P2 amplitude with 
increasing loudness) whereas subject 2 shows a shallow LDAEP (a small increase in N1/P2 
amplitude with increasing loudness). Adapted from O’Neill et al., 2008. (Reprinted by 
permission of author and publisher). 
There is evidence suggesting that the LDAEP is also modulated by dopaminergic 
neurotransmission (Juckel et al., 2008). High intensity dependence of auditory and visual 
evoked potentials were associated with low levels of dopamine metabolites (i.e., homvanillic 
acid) in cerebrospinal fluid and urine (Pogarell et al., 2004; O’Neill et al., 2008). Pogarell and 
colleagues (2004) used single photon emission computed tomography (SPECT) and showed 
that the LDAEP was positively associated with both serotonin and dopamine transporter 
availabilities in patients with OCD. Recently, Juckel and colleagues (2008) found that the 
LDAEP is also related with the genetic variants of the cCOMT—implicated in the 
inactivation of synaptic dopamine (Stein et al., 2005; Samochowiec et al., 2004). Reduced 
COMT activity caused by genetic polymorphisms was associated with a weaker LDAEP 
(Juckel et al., 2008).  
The LDAEP has been utilized to study dysfunctional serotonergic and dopaminergic activity 
in patients with GAD (Senkowski et al., 2003), PTSD (Park et al., 2010), schizophrenia (Juckel 
et al., 2003) or depression (Gallinat et al., 2000). Recently, Park and colleagues (2010) 
compared the results of the LDAEP in a variety of psychiatric patients including GAD, 
PTSD, panic disorder, bipolar depression, major depressive disorder (MDD), and 
schizophrenia. Individuals with different anxiety disorders produced different strengths of 
LDAEPs (see Fig. 3), which raised a possibility that the differences in the LDAEP may be 
associated with distinctive anxiety symptoms and cognitive impairments that characterize 
different subtypes of anxiety disorders. However, further studies are needed to explicate the 
relationship between different anxiety disorders and the strength of LDAEP.  
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Fig. 3. Comparison of the LDAEP among panic disorder (PD), generalized anxiety disorder 
(GAD), and post-traumatic stress disorder (PTSD). Note: Adapted and modified from Park 
et al. (2011). (Reprinted by permission of publisher).  
Furthermore, evidence suggests that the LDAEP can serve as a predictor of responses to 
SSRI treatment in GAD patients, which phenomenon was previously observed in patients 
with MDD (Gallinat et al., 2000; Linka et al., 2004). Research has indicated that a strong 
LDAEP— indicating lower serotonergic activity and turnover rate—is associated with a 
favorable response to SSRI treatment in patients with depression (Gallinat et al., 2000; Linka 
et al., 2004). Our study (Park et al., 2011) also showed that GAD patients who had stronger 
LDAEPs responded favorably to SSRI (escitalopram) treatment. Park et al. (2011) also 
confirmed this finding in the brain source activity of the LDAEP, which was measured using 
a standardized low resolution brain electro-magnetic tomography (sLORETA; Pascual-
Marqui, 2002). GAD patients who showed greater loudness dependence source activity in 
the primary auditory cortex were more responsive to the escitalopram treatment (see Fig. 4). 
The study (Park et al., 2011) implies that source activity of the LDAEP, as well as the cortical 
LDAEP, may play an important role in predicting the efficacy of SSRI treatment in GAD 
patients, which can be used in clinical settings. 
4.2 Other ERP components that are associated with neural mechanisms of cognitive 
bias 
Because of high-temporal resolution, the event-related potentials (ERP) method can be 
particularly useful to capture the time course of anxiety-related attentional biases (Mercade 
et al., 2009) and has been utilized in some studies (Holmes, et al., 2008; Bar-Haim et al., 
2005). Researchers have studied the P1—the first major positive voltage deflection occurring 
50-165 ms after the onset of stimulus—and the early posterior negativities (EPNs)—showing 
negative deflection over the temporo-occipital sites within a time window between 150 (200) 
and 300 ms—in response to emotional stimuli (Schupp et al. 2006; see Figure 5). A number of 
studies reliably found that negative faces elicited the significantly higher amplitude of the 
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Fig. 4. The source activities of ERP components (N1-P2) on the primary auditory cortex were 
obtained by the sLORETA program. And the linear regression slope of the source activities 
of five ERP components was considered as the sLORETA - loudness dependence of the 
auditory evoked potential (sLORETA-LDAEP). The sLORETA-LDAEP showed the 
significant positive correlation [Spearman’s rho = 0.54 (p=0.005)] with symptom response 
rates measured by Hamilton Anxiety Rating Scale (HAM-A) in patients with generalized 
anxiety disorder treated with escitalopram. Note: Adapted and modified from Park et al. 
(2011). (Reprinted by permission of publisher).   
exogenous visual P1 component (Pourtois et al., 2005; Holmes et al., 2008). Greater EPNs were 
observed in response to negative faces compared to positive and neutral faces over lateral 
posterior and occipital areas (Schupp et al., 2004b; Holmes et al., 2008). Similarly, Bublatzky 
and colleagues (2010) reported that emotional pictures elicited an enlarged EPN. The P1 and 
the EPNs are particularly useful because they are associated with the preferential attentional 
processing of negative facial expressions in extrastriate visual cortex, which is extensively 
modulated by the amygdala and attentional networks in fronto-parietal cortex (Homles et al., 
2008). Also, the EPN may be associated with a transient stage at which motivationally relevant 
stimuli are ‘tagged’ for prioritized processing, which can be useful to study preferential 
processing of motivationally relevant stimuli commonly observed in patients with anxiety 
disorders (Cuthbert et al. 2000; Michalowski et al. 2009; Schupp et al., 2006). In Holmes et al. 
(2008), high-trait anxiety participants who performed a variant of the emotional spatial cuing 
task showed an enhanced early P1 component to fearful faces relative to neutral faces at 
occipital electrode sites (Holmes et al., 2008). However, high-trait anxiety participants did not 
show greater lateral parietal negativities (or EPNs) in response to fearful faces, which may 
indicate attentional avoidance following the initial attentional vigilance or the failure to 
differentiate threat from non-threat stimuli (Holmes et al., 2008). In contrast, Wieser and 
colleagues (2010) reported that  that healthy participants who expected to make public 
speaking produced enhanced EPN responses for angry facial expressions, suggesting 
enhanced early perceptional processing of angry faces.   
Furthermore, Bar-Haim and colleagues (2005) used the emotional spatial cuing task similar 
to Fox et al., (2001) and reported high-trait anxiety participants had greater amplitudes of 
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the P2 component—the following major positive voltage deflection occurring 50-165 ms 
after the onset of stimulus—to angry faces compared to low-trait anxiety participants. 
Greater P2 components indicate greater attentional allocation to threat-related stimuli, 
which is frequently exhibited in individuals with anxiety disorders (Holmes et al., 2008).  
Rossignol and colleagues (2005) used an emotional oddball task in which participants were 
asked to detect an infrequent emotional target stimulus among a series of frequent neutral 
standard stimuli and provided evidence that anxiety modulated the amplitude of N300, a 
negative deflexion peaking at central sites around 300ms, and the latency of the P3b 
component, occurring at parietal situes around 450 ms. N300 is associated with affective 
processing and P3b reflects decision-making and premotor response-related stage 
(Rossignol et al., 2005). High-trait anxiety participant showed the reduced amplitude of 
N300 suggesting that they were less able to process the emotional content of faces. However, 
faster detection of infrequent emotional target stimuli as suggested by faster reaction time 
latency and the P3b latency indicated that high-trait anxiety participants made fast decisions 
and preparation for actions (Rossignol et al., 2005).  
 
 
Fig. 5. Illustration of P1, P2, P3, early posterior negativity (EPN), and late positive potential 
(LPP) in response to fearful target stimuli in the odd ball task. 
Another ERP component that has been used to study the abnormal processing of threat-
relevant stimuli in anxious individuals is the late positive potential (LPP)—which becomes 
apparent approximately 300 ms after stimulus onset (Hajcak et al., 2010). Research indicated 
that greater LPPs are observed in response to emotional compared to neutral stimuli and do 
not habituate to stimuli that are repeatedly presented (Cuthbert, Schupp, Bradley, 
Birbaumer, & Lang, 2000; Dillon, Cooper, Grent-’t-Jong, Woldorff, & LaBar, 2006; Foti, & 
Hajcak, 2008; Hajcak, Dunning, & Foti, 2007; Hajcak & Nieuwenhuis, 2006; Hajcak & Olvet, 
2008; Moser, Hajcak, Bukay, & Simons, 2006; Schupp et al., 2000; Schupp, Cuthbert et al., 
2004a; Schupp, Ohman et al., 2004b; Schupp, Junghöfer, Weike, & Hamm, 2003). The LPP is 
associated with sustained attention toward, and elaborative processing of, motivationally 
relevant stimuli, which phenomenon is commonly observed in patients with anxiety 
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disorders (Hajcak et al., 2010). The source activity of the LPP may be traced to occipital 
activation resulting from elevated amygdala activity to motivationally relevant stimuli 
(Hajcak et al., 2010). It has been suggested that the LPP may reflect activity in the locus 
coeruleus (LC)-Norepinephrine (NE) system that innervates large areas of the cortex in 
response to motivationally relevant stimuli (Hajcak et al., 2010). Research indicated that 
patients with anxiety disorders had larger LPP than health controls (Leutgeb et al., 2010; 
MacNamara & Hajcak et al., 2010). For instance, spider phobia patients showed enhanced 
LPP amplitude in response to spider pictures (Leutgeb et al., 2010). Also, GAD patients had 
larger LPPs to aversive targets presented with neutral distrators compared to healthy 
controls (MacNamara & Hajcak, 2010).   
There is an ERP component that can reflect prefrontal activity. For example, research has 
indicated that the error-related negativity (ERN), a negative deflection observed at fronto-
central sites, is generated in the anterior cingulate cortex (ACC; Olvet and Hajcak, 2008). The 
ERN arises around the time when an erroneous response is made and peaks at 50-100 ms 
after stimulus onset (see Figure 6). The ERN has been found across different types of the 
tasks that employed various stimuli and response modalities (Hajcak et al., 2003; Weinberg 
et al., 2010). Significantly larger ERN component has been associated with anxiety (Xiao et 
al., 2011). Undergraduate students who scored high on the Penn State Worry Questionnaire 
 
 
Fig. 6. Incorrect response is involved with the generation of ERN (error-related negativity). 
The ERN is negative-going deflection in averaged electrical brain activity that is time-locked 
to the execution of an incorrect response. Note that the ERN is absent for correct response. 
Note: Adapted and modified from Kim and Lee (2008). (Reprinted by permission of author 
and publisher).  
Had significantly greater ERN compared to both phobic and non-anxious participants when 
making errors in the Stroop task (Hajcak et al., 2003). Also, significantly larger ERN 
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amplitudes were observed in individuals who had high scores on negative affect scores on 
negative affect compared to those with low scores on NA (Hajcak et al., 2004). 
Administrating anxiolytics such as oxazepam and alprazolam has decreased ERN 
amplitudes (Johannes et al., 2001; Riba et al., 2005). Several studies showed that patients 
with OCD have been associated with enhanced ERN amplitudes which did not change after 
successful treatment (Endrass et al., 2010; Gehring et al., 2000; Hajcak et al., 2008). A recent 
study showed that GAD patients showed larger ERN relative to healthy controls (Weinberg 
et al., 2010). Olvet and Hajcak (2008) have proposed that error monitoring activity of the 
ACC indexed by the ERN may play a role as an endophenotype of anxiety disorders.  
5. Heart rate variability  
Patients with anxiety disorders are characterized by reduced heart rate variability (HRV; Ost 
et al., 1984; Friedman, 2007). HRV—which refers to the differences in beat-to-beat alterations 
in heart rate—indicates the dynamic interplay between sympathetic and parasympathetic 
(vagal) activity in the heart (Berntson et al., 1997; Task Force of the European Society of 
Cardiology and the North American Society of Pacing and Electrophysiology, 1996; Thayer 
and Lane, 2000). Under resting conditions, the heart is predominately under the control of 
the parasympathetic activity (Levy, 1971). Although the intrinsic heart rate is approximately 
105 beat per minute, resting heart rate is only 6o-80 beats per minute, indicating that the 
heart is under the strong vagal control (“vagal dominance”; Brownley et al., 2000; Ellis & 
Thayer, 2010)  
There is converging evidence suggesting that reduced HRV—indicating autonomic 
dysregulation associated with elevated sympathetic activity and reduced vagal activity of 
the heart—is commonly observed in patients with panic disorder,  GAD, and even children 
of patients with panic disorder (see Friedman, 2007 for a review; Friedman and Thayer, 
1998; Srinivasan et al., 2002). Research has indicated that reduced HRV is associated with 
predispositions to various physical and psychological illnesses and considered to be a 
predictor of all-cause mortality (Thayer and Lane, 2000). Also, reduced HRV is associated 
with reduced attentional control, poor emotional regulation, decreased response to various 
stimuli, and antisocial behavior in adolescents (Mezzacappa et al., 1997; Friedman, 2007; 
Thayer et al., 2000). Patients who experienced severe panic attacked frequently exhibited 
reduced HRV in various situations (e.g., quiet rest, shock avoidance, face immersion, 
isoproterenol infusions; Friedman et al., 1993; Yeragani et al., 1995). High trait anxiety was 
associated with autonomic dysreguation indexed by reduced HRV (Miu et al., 2009). Thus, 
reduced HRV may play a critical role in the development of anxiety disorders and can be 
considered as an important endophenotype of anxiety (Friedman, 2007; Crişan et al., 2009). 
In a recent review of the literature, Friedman (2007) provided a number of studies that 
linked reduced HRV with a variety of anxiety disorders over the past 15 years and provided 
the summary of the Neurovisceral Integration model of anxiety.    
5.1 The Neurovisceral Integration Model of anxiety 
Several researchers have identified neural networks in the central nervous system  
associated with autonomic, emotional, and cognitive self-regulatory responses, one of which 
is the central autonomic network (CAN; Benarroch, 1993; Thayer and Lane, 2000; 2002). The 
structures of the CAN include the anterior cingulate, insula, ventromedial prefrontal 
cortices, the central nucleus of the amygdala, the paraventricular and related nuclei of the 
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hypothalamus, the periaquaductual gray matter, the parabrachial nucleus, the nucleus of the 
solitary tract (NTS), the nucleus ambiguous, the ventrolateral medulla, the ventromedial 
medulla, and the medullary tegmental field (for reviews, Ellis and Thayer, 2010; Thayer and 
Lane, 2002). Reciprocally interconnected components in the CAN allow information to flow 
in both top-down and bottom-up fashions (Theyer and Lane, 2000, 2002). Also, these 
components are loosely connected so that it is possible to recruit additional structures when 
it is necessary to make specific behavioral adaptations (Thayer and Lane, 2000, 2002).  
In the CAN, the prefrontal cortical structures—including the orbitofrontal cortex (OFC) and 
medial prefrontal cortex (mPFC)—modulates cardiovascular, autonomic, and endocrine 
responses by exerting tonic inhibitory control on subcortical structures, such as the central 
nucleus of the amygdala (Thayer and Lane, 2000; Thayer et al., 2009). In emotionally 
stressful and threatening situations, sympathoexcitatory subcortical circuits are activated to 
produce the fight or flight response (Thayer and Lane, 2000; Thayer and Seigle, 2002). 
However, the constant activation of sympathoexcitatory subcortical activity is not suitable 
for many other situations and will eventually wear and tear the system down. Therefore, 
sympathoexcitatory subcortical activity has to be controlled, and research indicated that the 
PFC—typically associated with governing higher cognitive functions—is involved in 
regulating activity in sympathoexcitatory subcortical circuits (Thayer et al., 2009). In 
emotionally stressful situations, the prefrontal cortex disinhibits its inhibitory control over 
sympathoexcitatory subcortical circuits and lets subcortical neural structures such as the 
amygdala make autonomic and prepotent responses to situations (Thayer et al., 2009). 
However, when identifying certain safety signals, the PFC exerts its inhibitory control over 
sympathoexcitatory subcortical circuits and makes responses that are appropriate for 
contexts in which the signals occur. Therefore, the inhibitory cortical-subcortical circuit is 
critical for self-regulation (Thayer and Lane, 2000; 2002). On the other hand, the breakdown 
of the inhibitory mechanism can result in the constant activation of sympathoexcitatory 
subcortical circuits, which may lead to emotional, attentional, and autonomic dysreguation 
and the emergence of perseverative behavior such as worry. Neurochemically, tonic 
inhibitory control is achieved by γ-aminobutyric acid (GABA) activity within the NTS and 
reduced GABA activity has been also associated with anxiety, perseverative cognition and 
poor habituation (Malizia et al., 1998; Friedman, 2007; Thayer and Lane, 2000). 
The complex neutral circuits link the inhibitory cortical and subcortical pathways with the 
heart via the vagus nerve (for reviews, see Benarroch, 1993; Ellis & Thayer, 2010; Thayer et al., 
2009). High vagally-mediated HRV indicates an exertion of good cognitive, emotional and 
physiological self-regulation, which is associated with highly integrated cortical-subcortical 
circuits (Thayer et al., 2009). In contrast, low HRV is associated with poor regulatory systems 
resulting from the lack of prefrontal regulation over subcortical activity, which is behaviorally 
manifested through hypervigilance, the failure to habituate to novel, nonthreatening stimuli, 
and perseverative behavior such as worry (Friedman, 2007; Thayer et al., 2009).   
There exists the relationship between serotonergic activity and HRV. HRV is positively 
related to serotonin turnover (DePetrillo et al., 1999). Individuals carrying s allele of 
serotonin transporter gene showed reduced HRV compared to l-homozygotes (Crişan et al., 
2009). Lower levels of serotonin induced by tryptophan depletion were associated with 
reduced HRV in remitted depressed patients (Booij et al., 2005). Thayer and Ruiz-Padial 
(2006) suggested that reduced HRV may also indicate the altered coupling or breakdown of 
the connectivity between the PFC and the amygdala typically exhibited in individuals 
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carrying s allele (Heinz et al., 2005; Pezawas et al., 2005). Increased vagally-mediated HRV 
was observed after SSRI treatment in panic patients (Tucker et al., 1997) and PTSD (Cohen et 
al., 2000).  
6. Conclusion  
In this chapter, we presented potential psychophysiological markers that have been studied 
in anxiety research. A weak LDAEP may indicate dysfunctional serotonergic activity 
associated with patients with anxiety disorders. Patients with different subtypes of anxiety 
disorders may be associated with distinctive LDAEPs and that the LDAEP may serve as a 
predictor of SSRI treatment outcome in patients with GAD. Also, other ERP components 
(e.g., P1, P2, N300, P3b, EPN, LPP and ERN) have been useful in studying attentional biases 
favoring threat-relevant stimuli in highly anxious individuals. Patients with anxiety 
disorders typically show reduced HRV—indicating autonomic dysfunction caused by 
elevated sympathetic and reduced vagal cardiac control (Friedman, 2007). Accumulated 
evidence suggests that reduced HRV—linked with anxiety disorders—may contribute to 
poor emotional and cognitive self-regulation, the failure of inhibition at multiple levels and 
perseverative cognition such as worry (Friedman, 2007).  
The genetic, cognitive, and psychophysiological characteristics may interact with each other 
and with other environmental factors such as stress to produce or exacerbate different 
symptoms in anxiety disorders. Future work may benefit from integrating these markers 
and exploring the relationships with genetic predispositions to the psychopathology. Of 
clinical importance is whether these potential psychophysiological markers may play a role 
in predicting the efficacy of psychological and medical treatments, which is yet to be 
determined.  
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